EPISODE · Aug 21, 2018 · 1H 6M
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH
We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.
What this episode covers
We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.
NOW PLAYING
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.